The Breast Tumor Microenvironment: A Key Player in Metastatic Spread

Abstract

The tumor microenvironment plays a pivotal role in the tumorigenesis, progression, and metastatic spread of many cancers including breast. There is now increasing evidence to support the observations that a bidirectional interplay between breast cancer cells and stromal cells exists within the tumor and the tumor microenvironment both at the primary tumor site and at the metastatic site. This interaction occurs through direct cell to cell contact, or by the release of autocrine or paracrine factors which can activate pro-tumor signaling pathways and modulate tumor behavior. In this review, we will highlight recent advances in our current knowledge about the multiple interactions between breast cancer cells and neighboring cells (fibroblasts, endothelial cells, adipocytes, innate and adaptive immune cells) in the tumor microenvironment that coordinate to regulate metastasis. We also highlight the role of exosomes and circulating tumor cells in facilitating breast cancer metastasis. We discuss some key markers associated with stromal cells in the breast tumor environment and their potential to predict patient survival and guide treatment. Finally, we will provide some brief perspectives on how current technologies may lead to the development of more effective therapies for the clinical management of breast cancer patients.

The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies

“…Increasing evidence supports the vital role of TME during cancer development [ 21 ]. Complex TME is composed of various cells, including stromal cells and immune cells.…”

The Role of Decorin Proteoglycan in Mitophagy

“…In spite of the significant advances in breast cancer diagnosis and treatment, this malignant neoplasm is still the most common cancer diagnosed among women and represents the second leading cause of cancer mortality in the United States after lung cancer [1]. One of the most striking features of mammary carcinomas is their heterogeneity both in terms of tumor cell types and the stroma, an associated tissue long considered an active participant in malignant behavior, metastatic spreading, and colonization of distant organs [2][3][4][5][6]. Indeed, intratumor heterogeneity has been proposed to represent the "Rosetta Stone" of therapy resistance [7].…”

The Binomial “Inflammation-Epigenetics” in Breast Cancer Progression and Bone Metastasis: IL-1β Actions Are Influenced by TET Inhibitor in MCF-7 Cell Line

“…Different molecules are involved in the intricate network of signaling pathways able to orchestrate communication between cancer cells and the surrounding stroma. The microenvironment is critical for promoting tumor progression and to attract metastasizing cancer cells to bone [ 3 ]. The most recent advances to understand tumor–microenvironment interactions have elucidated the crucial role of the immune system, in particular of the inflammatory process, in supporting or inhibiting tumor progression and metastasis [ 3 ].…”

“…The microenvironment is critical for promoting tumor progression and to attract metastasizing cancer cells to bone [ 3 ]. The most recent advances to understand tumor–microenvironment interactions have elucidated the crucial role of the immune system, in particular of the inflammatory process, in supporting or inhibiting tumor progression and metastasis [ 3 ]. In breast cancers, the alteration of DNA methylation is a prevalent epigenetic feature associated with an increased risk of metastasis and poor prognosis.…”